Our name says it all.
While our company is not the first to develop antiviral therapeutics or cancer vaccines, we are the first to utilize the power of protein haptenization in a way that leverages the potential of T cells to specifically eliminate viral or tumor targets. Our core technology builds on the work of Nobel Prize winner Dr. Karl Landsteiner and the extensive clinical research into haptenized protein vaccines of our founding scientist. We expect to advance our portfolio of preclinical and clinical stage programs that are focused on creating novel biological vaccine systems for life-threatening viral infections and cancers.
We are a challenging, fast moving, and collaborative team looking for individuals to join us as we work to develop a vaccine for SARS-CoV-2 and advance our immunotherapeutic vaccine for patients with cancer. We are passionate about what we do. Come join us!
To apply for open positions, qualified candidates should send resume and cover letter to email@example.com
Note to recruiters:
BioVaxys only accepts applications or inquiries directly from candidates for posted or future positions. BioVaxys has no obligation to provide any form of compensation in return for any unsolicited referrals, references or resumés received without a previously established recruiting contract.
Copyright © 2020 BioVaxys Inc.- All Rights Reserved.